Wutah pendapatan taun lumaku: Silexion Therapeutics Corp (SLXN)

Logo perusahaan publik Silexion Therapeutics Corp. (SLXN)

Silexion Therapeutics Corp (SLXN) operates in a stable environment, remaining shielded from trade conflicts. The company's success is based on the effectiveness of combating KRAS mutations in pancreatic cancer. This chart of trailing 12-month YoY revenue growth visualizes these processes, where 0.00 reflects the latest metric value. Structural flexibility is ensured by fully outsourcing production and clinical trials to third-party contractors.

Silexion Therapeutics (SLXN): Wutah pendapatan YoY sajrone 12 wulan kepungkur saka 23.11.2025 nganti 19.11.2026

Silexion Therapeutics - rincian analitis lan metrik utama (SLXN)

- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:silexion.com
Produk merek silexion.com

Revenue dynamics allow for an assessment of business resilience to market shocks, which is critical for Silexion Therapeutics Corp (SLXN) given its large-scale investments in AI-driven RNA modeling for tumor therapy. By analyzing the trailing twelve-month (TTM) sales growth, an investor can observe daily revenue changes over a 12-month period, providing an objective characterization of management efficiency, although sharp spikes in growth rates may signal that the asset is overbought.

Karo sapa Silexion Therapeutics Corp saingan

Incyte Pharma - Wutah dodolan YoY sajrone rolas wulan kepungkur|HUTCHMED Corp - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Nuvation Bio Inc.|DAWN: Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Monopar Pharma MNPR|Wutah pendapatan YoY sajrone 12 wulan kepungkur INBX|Wutah pendapatan taun lumaku I-Mab Biopharma IMAB|Wutah pendapatan YoY sajrone 12 wulan kepungkur FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Nuvectis Pharma, Inc. - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur CHRS (Coherus BioSciences)|Corbus Pharma - Wutah dodolan YoY (TTM)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur CRDF (cardiffoncology.com)|BYSI: Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku BioAtla Corp (BCAB)|Wutah dodolan YoY sajrone rolas wulan kepungkur Lixte Biotechnology Holdings, Inc.|CTXR: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) CLRB|Wutah dodolan YoY (TTM) BioLineRx Corporation (BLRX)|Wutah dodolan YoY sajrone rolas wulan kepungkur Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Wutah dodolan taun lumaku|KZIA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku NuCana|CMRX: Wutah dodolan YoY (TTM)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Wutah dodolan YoY (TTM)|KRON: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Kintara (KTRA)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Oncternal ONCT|Portage Biotech - Wutah pendapatan YoY sajrone 12 wulan kepungkur